# Panacea Longevity

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/panacea-longevity

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.panacealongevity.com/
- Latest round: Seed (Feb 1, 2021)
- Investors on record: 2

## About

Panacea Longevity, Inc. develops innovative health solutions aimed at optimizing metabolism and promoting longevity through its flagship biomimetic fasting mimetic product, designed for health-conscious consumers and athletes.Panacea Longevity, Inc. focuses on health solutions, particularly through its flagship product, a biomimetic fasting mimetic that optimizes metabolism. Founded in 2019 in San Francisco, US, the company has completed one significant deal as of February 1, 2021. The co-founders, Angela Zivkovic and Christopher Rhodes, have a history of entrepreneurship, with Christopher Rhodes currently serving as CEO.Mimio, the flagship product of Panacea Longevity, Inc., is designed to enhance metabolic efficiency and promote longevity by utilizing clinically validated fasting metabolites. This biomimetic fasting mimetic allows users to experience fasting benefits without abstaining from food, targeting health-conscious consumers and athletes. The product, based on seven years of clinical research, is available across North America, Europe, and Asia, catering to those looking to improve their metabolic health and overall well-being.Mimio generates revenue through direct-to-consumer sales via its e-commerce platform, where customers can easily order the fasting mimetic product for home delivery. The company offers subscription options to ensure regular customers can receive their products consistently, promoting customer retention and stable revenue. Although specific pricing information is not disclosed, the business model indicates a focus on providing high-quality health supplements for the growing wellness and longevity market.Following their recent Seed funding round in February 2021, led by SOSV and IndieBio, Panacea Longevity, Inc. plans to utilize the capital to support the development of new products and to expand into additional markets. Targeted expansions include increasing their presence in North America, Europe, and Asia. Upcoming product launches are expected as the company continues to innovate in health solutions, leveraging insights gained from their extensive research.

## Funding rounds

- Seed, Feb 1, 2021 — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed